The HCV saga goes on: Epclusa has been approved for treatment of chronic Hepatitis C virus (HCV) infection
June 29, 2016 – The saga goes on: The American Food & Drug Administration (FDA) just approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) infection both with and without cirrhosis (advanced liver disease). For patients with …